Skip to Content

Rexista Approval Status

  • FDA approved: No
  • Brand name: Rexista
  • Generic name: oxycodone hydrochloride
  • Dosage form: Extended-Release Tablets
  • Company: Intellipharmaceutics International Inc.
  • Treatment for: Pain

Rexista (oxycodone hydrochloride extended release) is an abuse and alcohol-deterrent controlled-release formulation of oxycodone hydrochloride in development for the relief of moderate to severe pain.

Development Status and FDA Approval Process for Rexista

Sep 25, 2017Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista NDA
Feb  2, 2017Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista (oxycodone hydrochloride extended release) Abuse Deterrent Opioid Analgesic
Nov 25, 2016Intellipharmaceutics Submits NDA for Rexista (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
May 21, 2015Intellipharmaceutics Intends to Accelerate its Rexista Oxycodone XR Development Program on the Basis of Positive Feedback from the FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.